Susquehanna International Group, LLP Acadia Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $566,236 - $715,836	37,400 Added 73.77%	88,100 $1.36 Million
Q2 2024 Aug 15, 2024	SELL	$14.62 - $18.42 $1.8 Million - $2.26 Million	-122,800 Reduced 70.78%	50,700 $823,000
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $1.52 Million - $2.64 Million	85,400 Added 96.94%	173,500 $3.21 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $11.1 Million - $16.9 Million	-532,300 Reduced 85.8%	88,100 $2.76 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $11.8 Million - $18.9 Million	564,100 Added 1001.95%	620,400 $12.9 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $247,420 - $356,535	13,900 Added 32.78%	56,300 $1.35 Million
Q1 2023 May 16, 2023	BUY	$16.32 - $20.92 $324,768 - $416,308	19,900 Added 88.44%	42,400 $797,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $1.28 Million - $1.68 Million	-90,100 Reduced 80.02%	22,500 $358,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $2.49 Million - $3.23 Million	-176,800 Reduced 61.09%	112,600 $1.84 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.7B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.